Advances in Mucoadhesive Polymers and Formulations for Transmucosal Drug Delivery |
Autore | Khutoryanskiy Vitaliy |
Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
Descrizione fisica | 1 electronic resource (206 p.) |
Soggetto non controllato |
chitosan
maltodextrin Caco-2 cells alkyl lactate mucosal drug delivery thermogelling polymers buccal mucosa drug delivery drug delivery triple co-culture model oral lichen planus mucoadhesive polymers cyclodextrins paediatric mucoadhesion nanoparticles pectin furosemide oral lyophilisates films wound healing pluronic f127 interpolymer complexes transmucosal permeations Alzheimer’s disease biocompatibility poly (vinylpyrrolidone) mucosal membranes scanning electron microscopic images pioglitazone hydrogel resuspendibility thermoresponsive polymers mucoadhesive microspheres trimethyl chitosan Candida albicans xanthan gum omeprazole texture profile analysis acrylated chitosan mucoadhesive clotrimazole clobetasol Carbopol® hydroxypropyl cellulose electrospinning chitosan derivatives in vitro permeability l-arginine resveratrol cytotoxicity retention thiolated hyaluronic acid Carbopol mucoadhesive polymer rheology Eudragit® E PO detachment force chitosan-catechol controlled release PLGA-PEG liposphere gellan gum storage and loss moduli thiolated chitosan interpolyelectrolyte complex poly(2-ethyl-2-oxazoline) |
ISBN | 3-03928-753-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910404086403321 |
Khutoryanskiy Vitaliy
![]() |
||
MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
New Therapies of Liver Diseases |
Autore | Toniutto Pierluigi |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (236 p.) |
Soggetto topico | Public health & preventive medicine |
Soggetto non controllato |
tolvaptan
cirrhotic ascites survival rate furosemide primary biliary cholangitis autoantibodies ursodeoxycholic acid treatment response second line therapy primary biliary cholangitis (PBC) primary sclerosing cholangitis (PSC) clinical trials ursodeoxycholic acid (UDCA) Farnesoid X Receptor (FXR) agonist Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists liver cancer systemic treatment immunotherapy real-world unresectable hepatocellular carcinoma cirrhosis decompensation bleeding varices survival infection alcoholic hepatitis acute-on-chronic liver failure cholangiocarcinoma colorectal cancer metastases hepatocellular carcinoma liver transplantation Milan criteria alpha-fetoprotein solid organ transplantation liver injury immunosuppressant SARS-CoV-2 humoral response vaccination portal-systemic shunt ammonia vigilance HBV HDV antivirals functional cure pharmacology acute-on-chronic liver failure (ACLF) liver transplantation (LT) decompensated cirrhosis portal hypertension ascites non-selective beta-blockers TIPS rifaximin human albumin statins targeted therapy effective hypovolemia anti-mineralocorticoids loop diuretics vaptans |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910566457403321 |
Toniutto Pierluigi
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Regional Intestinal Drug Absorption : Biopharmaceutics and Drug Formulation |
Autore | Gonzalez-Alvarez Maria Isabel |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (238 p.) |
Soggetto topico |
Medicine
Pharmaceutical industries |
Soggetto non controllato |
bioequivalence
Biopharmaceutics Classification System in vitro dissolution test pravastatin oral absorption in silico modeling GastroPlus Phoenix WinNonlin pharmacokinetics clinical studies ibuprofen manometry gastrointestinal mechanistic modeling PBPK PBBM disintegration dissolution enteric-coated ICH quality control regional intestinal permeability permeation enhancers absorption-modifying excipients oral peptide delivery intestinal perfusion pharmaceutical development controlled release drug product biopharmaceutics classification system drug solubility drug permeability location-dependent absorption segregated flow intestinal model (SFM) traditional model (TM) route-dependent intestinal metabolism first-pass effect drug-drug interactions DDI in vitro in vivo extrapolations IVIVE zero-order absorption first-order absorption combined zero- and first-order absorption transit compartment absorption model in situ perfusion microdevices shape mucoadhesion colon absorption nutrient digestion nutrient absorption gastrointestinal hormone postprandial glycaemia energy intake region of the gut obesity type 2 diabetes Franz–PAMPA BCS drugs biomimetic membrane Franz cell passive drug transport BCS class IV drugs segmental-dependent intestinal permeability intestinal absorption oral drug delivery biopharmaceutics physiologically-based pharmacokinetic (PBPK) modeling furosemide intestinal permeability human colon carcinoma cell layer (Caco-2) hierarchical support vector regression (HSVR) drug absorption drug solubility/dissolution regional/segmental-dependent permeability and absorption |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Regional Intestinal Drug Absorption |
Record Nr. | UNINA-9910566462603321 |
Gonzalez-Alvarez Maria Isabel
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|